Xenon Pharmaceuticals
XENE
#2869
Rank
NZ$10.37 B
Marketcap
NZ$107.18
Share price
5.58%
Change (1 day)
62.54%
Change (1 year)

Market capitalization of Xenon Pharmaceuticals (XENE)

Market cap: NZ$10.37 Billion

As of August 2026 Xenon Pharmaceuticals has a market cap of NZ$10.37 Billion. This makes Xenon Pharmaceuticals the world's 2869th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Xenon Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$10.37 B67.63%
2025NZ$6.19 B16.58%
2024NZ$5.31 B-3.12%
2023NZ$5.48 B41.15%
2022NZ$3.88 B64.62%
2021NZ$2.35 B216.16%
2020NZ$0.74 B36.25%
2019NZ$0.54 B126.12%
2018NZ$0.24 B238.36%
2017NZ$71.59 M-64.01%
2016NZ$0.19 B17.7%
2015NZ$0.16 B-52.73%
2014NZ$0.35 B

End of Day market cap according to different sources

On Aug 26th, 2026 the market cap of Xenon Pharmaceuticals was reported to be:

NZ$10.37 Billion
by Nasdaq info icon info icon
NZ$10.37 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Coherus BioSciences
CHRS
NZ$0.37 B-96.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Atara Biotherapeutics
ATRA
NZ$0.15 B-98.48%๐Ÿ‡บ๐Ÿ‡ธ USA